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Background 
Polyether ionophore antibiotics, colloquially referred to as ionophores, are chemical compounds 
that are made by Streptomyces and other actinomycetes (Kevin, 2009). A number of ionophores 
have been characterized but only a few are used in veterinary medicine. The antibiotic activity of 
lasalocid was described in 1951 (Berger, 1951 ), but monensin was the first ionophore to be 
chemically characterized and commercialized (Chapman, 2010). As such, monensin is the best-
studied ionophore of the group and serves as the representative member of this class of 
antibiotics. The approval of other ionophore antibiotics soon followed and the introduction of 
new products continued for some 20 years. The last ionophore antibiotic to be approved in the 
US was semduramicin in 1995 (Jeffers, 2011 ). 
lonophores are used in both poultry and swine, but for different purposes. lonophores are used 
exclusively in poultry as an aid in the prevention of coccidiosis. Six different ionophores are 
currently available for use as coccidiostats in broiler chickens (Table 1 ). Narasin (Skycis® 100) 
has been recently approved for use in growing-finishing swine for improved feed efficiency and 
increased weight gain (FOi NADA 141-340). Presently, there are no FDA-approved products for 
the control of coccidiosis in swine. This paper provides an overview of the salient features of 
ionophores and their use in monogastric species. 
Table 1. lonophore antibiotics used in US poultrya 
lonophore 
Lasalocid 
Maduramicin 
Monensin 
Narasin 
Salinomycin 
Semduramicin 
aAnimal Drugs@FDA 
Use of lonophores in Broilers 
Approval 
1976 
1989 
1971 
1988 
1983 
1995 
Trade Name 
Avatec® 
Cygro® 
Coban® 
Monteban® 
Bio-Cox®; Sacox® 
Aviax® 
Coccidiosis is a parasitic disease that causes significant economic losses to the poultry industry 
in both the US and worldwide (Anonymous, 2013). lonophores have been key tools in the fight 
against this disease for over 40 years (Kevin, 2009; Chapman, 2010). The causative agent, 
Eimeria, has a complex lifestyle which involves both intracellular and extracellular life forms. 
Monensin is active against sporozoites and merozoites, the extracellular motile forms of the 
parasite (Chapman, 201 O). It has been said that the growth of the poultry industry owes much to 
the introduction of ionophore antibiotics (Jeffers, 2011 ). 
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lonophores achieve their anti-parasitic effects in a unique way. Cells generate electrical energy 
to transport various substances across the membrane. This is accomplished by actively 
maintaining high and low concentrations of various ions in the cell relative to the external 
environment. For example, the intracellular concentration of potassium ions (K+) is higher than 
that of sodium ions (Na+) and the opposite is true in the extracellular environment. lonophores 
transport additional ions such as calcium (Ca +2), potassium (K+) and sodium (Na+) into the cell 
thereby disrupting these essential ion gradients (Kevin, 2009; Rutkowski, 2013). The cell 
expends energy to regain ion homeostasis but to no avail. 
lonophore-treated sporozoites and merozoites exhibit morphological changes in vitro such as 
swelling of the cell and mitochondria, vacuolation, blebbing and disintegration (Smith, 1981; 
Mehlhorn, 1983; Chapman, 2010). The accumulation of Na+ in the cell and the concomitant 
influx of water results in osmotic damage and the bursting of the cell (Chapman, 2010). In vitro 
assays have shown that monensin-treated sporozoites lose their ability to invade host cells 
(Smith, 1981; Augustine, 1986). This may be due to a disruption of membrane signaling 
pathways that are essential for entry into the host (del Cacho, 2007). In vivo, the treatment of 
Eimeria-infected broilers with lasalocid resulted in the formation of degenerate intracellular 
sporozoites (Daszak, 1991 ). Morphologically aberrant merozoites were also observed in 
damaged host cells and in the lumen (Daszak, 1991 ). 
lonophore-resistant coccidia have been described for years (Chapman, 2010). However, such 
isolates are best described as having reduced susceptibility to these antibiotics (Chapman, 
2010). Birds infected with such strains have been shown to have reduced weight gains, 
decreased feed efficiency, higher lesion scores, and higher oocyte production, but not frank 
disease (Wang, 2006; Chen, 2008; Jenkins, 2010). Changes in parasite susceptibility are 
associated with decreased membrane fluidity, decreased antibiotic uptake and a host of 
changes in gene expression (Augustine, 1987; Wang, 2006; Chen, 2008). With regards to the 
latter, genes involved in the creation of the extracellular matrix were up-regulated and genes 
involved in energy generation were down-regulated (Chen, 2008). Reduced ionophore 
susceptibility in Eimeria does not necessarily equate with reduced efficacy in the field (Jeffers, 
2013). Explanations for this include the inability of Eimeria to acquire full resistance to 
ionophores and the development of immunity in treated birds (Jeffers, 2011 ). 
Despite sanitation measures, Eimeria oocytes persist in the rearing environment and birds are 
continually at risk for infection. As such, anticoccidial agents are administered to birds 
throughout their lifetime (Anonymous, 2008; Chapman, 2010). These agents include chemicals, 
ionophores and vaccines. Maximum year-round protection against coccidiosis in successive 
flocks usually involves the strategic use of all of these tools. Combination products containing 
an ionophore and a chemical, e.g. narasin and nicarbazin, act synergistically and stem the 
development of coccidia isolates with reduced susceptibility (Jeffers, 2011 ). The rotation of 
products from flock to flock is also effective at maintaining control. The use of a vaccine after a 
round of treatment of ionophores can help restore full susceptibility to Eimeria populations in the 
rearing environment (Chapman, 2010). 
Use of Narasin in Swine 
In addition to Eimeria, ionophores also have activity against Gram-positive bacteria (Kevin, 
2009; Rutkowski, 2013). Gram-negative bacteria are not susceptible to ionophores because the 
outer membrane prevents their access to the cell membrane. lonophores kill susceptible 
bacteria using a mechanism of action that is similar to that in coccidia. However, the ultimate 
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lethal event in bacteria is the depletion of energy stores. Treated cells do not burst because the 
rigid bacterial cell wall prevents osmotic rupture. Rather, after an ionophore-mediated influx of 
ions, the bacterial cell futilely attempts to regain homeostasis until there is not enough cellular 
ATP left to sustain growth (Russell, 1987; Newbold, 2013). The activity of ionophores against 
Gram-positive bacteria is an added benefit in trec;3ted broilers because it provides additional 
protection against necrotic enteritis, which is caused by Clostridium perfringens (Golder, 2011 ). 
Narasin increases weight gain and improves feed efficiency in swine by dual mode of action in 
selectively altering the microbial population in both the foregut and hindgut. lonophore activity 
against Gram-positive bacteria is well documented (Kevin, 2009; Rutkowski , 2013) and act in 
similar manner as other classes of sub-therapeutic antibiotics in the foregut. Wuethrich (1998) 
demonstrated that pigs fed low levels of narasin (15 ppm) had improvement (P<0.03) in nitrogen 
digestibility and retention. An internal Elanco metabolism study (T1XCA0202) supported the 
work of Wuethrich (1998) in finding that the addition of 15 ppm of narasin in the diet of growing 
pigs increases apparent nitrogen retention (62.02 vs. 56.14%), phosphorous retention (47.64 vs. 
40.61 %) and ileal energy digestibility (2726 Kcal vs. 2660 Kcal). Thacker (1992) using a 
different ionophore (salinomycin at 25 ppm) in growing pigs noted a similar increase in protein 
digestibility (P<0.05) when rye based diets were supplemented with salinomycin (25 ppm) alone 
or in conjunction with a beta-glucanase enzyme. {NOTE - Salinomycin is NOT approved for 
use in pigs in the United States). 
Similarly, ionophores also alter the micro flora of the hindgut, which can provide up to 20 to 30% 
of maintenance energy needs (Yen, 1991 ). Wuethrich and colleagues (1998) examined the 
impact of an ionophore (narasin at 15 and 30 ppm) on the VFA production in the cecum, second 
loop of distal colon and transverse colon. Their findings indicate that the dietary addition of an 
ionophore increased propionic acid concentration relative to acetic or butyric in a dose 
dependent manner. This shift in VFA production results in an increase of absorbed 
gluconeogenic precursors and decreases net energy losses through methane gas production as 
a by-product of acetic and butyric acid fermentation (Wuethrich 1998). Using the energy 
conversion efficiency of VFA suggested by Bergman (1989), propionic acid will provide 734 
Kcal/mole as compare to 419 and 524 Kcal/mole for acetic and butyric acids and therefore 
increase whole body energetic efficiency. 
Difference in Resistance Development 
In bacteria, ionophore resistance occurs as a result of persistence. Although bacterial 
populations are genetically identical, some heterogeneity in gene expression can occur, which 
results in physiological differences from one cell to another. These slight differences may allow 
the bacteria to grow in the presence of an antibiotic without the acquisition of true resistance 
(Levin, 2004; Shah, 2006; Dhar, 2007; Girgis, 2012). For example, persisters that grow more 
slowly are not killed by ampicillin because the antibiotic targets actively-growing cells (Balaban, 
2004). Likewise, persisters that produce extra polysaccharide survive amoxicillin treatment 
(Girgis, 2012). Persistence is considered to be a survival mechanism under adverse growth 
conditions and the "resistant" phenotype is lost after the antibiotic is removed (Girgis, 2012). 
Monensin-treated bacteria exhibit the hallmarks of persistence: slower growth, mixed cultures 
containing both susceptible and resistant cells, transient resistance and increased capsule 
production (Russell, 2003; Simjee, 2012). 
There are concerns that the use of antibiotics in food animals will lead to the development of 
antibiotic-resistant foodborne bacteria. Humans exposed to these bacteria may become sick 
with infections that cannot be effectively treated with antibiotics. The use of ionophores in 
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monogastric species does not lead to such problems. Gram-positive foodborne bacteria do not 
acquire ionophore resistance (Butaye, 2003; Aarestrup, 2011; Simjee, 2012). With no 
monensin-resistant bacteria or inheritable or transferable monensin resistance genes, cross-
resistance with other human use antibiotics and co-selection of other types of resistance genes 
are not a concern. lonophores are not currently used in human medicine because of their 
toxicity profiles (see below) and treatment failure is not of concern (Kevin, 2009). 
Toxicity 
Individual animal species differ in their tolerance to ionophore antibiotics. For example, the oral 
LD50 of monensin in chickens is 200 mg/kg and that of horses is 2-3 mg/kg (Kart, 2008). Toxicity 
and death can occur when animals are overdosed or if non-target animals intentionally or 
unintentionally consume ionophores (Kart, 2008; Kevin, 2009). In animals, the interference of 
ion flux in cells may lead to, among others, cardiac muscle damage, pulmonary edema, and 
neuropathy (Kart, 2008). The types of adverse events that are observed is animal species-
specific (Kart, 2008; Kevin, 2009). Toxicity may also result from the simultaneous treatment of 
animals with an ionophore antibiotic and tiamulin (Islam, 2009). Tiamulin interferes with the 
metabolism of ionophores and toxic levels accumulate in the body. Not all dual dosing 
conditions lead to toxicity (Islam, 2009; Weber, 2013). Toxicity was not observed in swine given 
full dietary doses of narasin (30 ppm) and tiamulin (40 ppm) (Weber, 2013). 
Summary 
Polyether ionophores have successfully been used in food animals for the past 40 years; first in 
ruminants to improve performance by altering VFA production patterns, secondly as effective 
coccidiostatic agents in broilers and lastly to improve growth and feed utilization in growing-
finishing swine. lonophore's unique mode of action by attaching to the cell wall of coccidia and 
Gram-positive bacteria allowing influx of extracellular ions has proven effective and resulted in a 
very low incidence of resistance in all target animal species. However, caution must be 
observed when using ionophores as toxicity is a concern in non-targeted species and 
concomital treatment of swine with tiamulin. lonophores have been deemed as a "non-medically 
important" class of antibiotic by FDA under GFI document #152; thus offering broiler producers 
effective coccidiosis control and treatment and swine producers an effective growth 
performance product that can be an alternative to traditional "medically important" antibiotics. 
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